Reply: Arterial Thromboembolism in Non-Hodgkin Lymphoma, as the Presentation of Occult Cancer, and With Cancer Therapies

Free article

Comment

Babak B Navi et al. J Am Coll Cardiol. 2018.

Free article

. 2018 Jan 16;71(2):260-262.

doi: 10.1016/j.jacc.2017.10.088.

No abstract available

Comment on

Risk of Arterial Thromboembolism in Patients With Cancer.
Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Elkind MSV, Panageas KS, DeAngelis LM. Navi BB, et al. J Am Coll Cardiol. 2017 Aug 22;70(8):926-938. doi: 10.1016/j.jacc.2017.06.047. J Am Coll Cardiol. 2017. PMID: 28818202 Free PMC article.
Arterial Thromboembolism in Non-Hodgkin Lymphoma.
Sorigue M, Sarrate E, Franch M, Sancho JM. Sorigue M, et al. J Am Coll Cardiol. 2018 Jan 16;71(2):258-259. doi: 10.1016/j.jacc.2017.09.1155. J Am Coll Cardiol. 2018. PMID: 29325650 No abstract available.
Recurrent Late Bioresorbable Scaffold Thrombosis as a Presenting Symptom of Underlying Cancer.
Leening MJG, Weevers APJD, van Geuns RM, Deckers JW, Levin MD. Leening MJG, et al. J Am Coll Cardiol. 2018 Jan 16;71(2):259-260. doi: 10.1016/j.jacc.2017.10.086. J Am Coll Cardiol. 2018. PMID: 29325651 No abstract available.
Risk of Arterial Thrombosis in Cancer Patients: Which Role for Cancer Therapies Vascular Toxicities?
Frere C, Martin-Toutain I, Thuny F, Bonello L. Frere C, et al. J Am Coll Cardiol. 2018 Jan 16;71(2):260. doi: 10.1016/j.jacc.2017.10.087. J Am Coll Cardiol. 2018. PMID: 29325652 No abstract available.